Boxer Capital, LLC Seagen Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $25.5 Million - $40.6 Million	200,000 New	200,000 $40.5 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $57 Million - $67.9 Million	-400,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $55 Million - $76.3 Million	400,000 New	400,000 $55.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.